title: In vitro Natural Killer Cell Immunotherapy for Medulloblastoma.
abstract: How the immune system attacks medulloblastoma (MB) tumors effectively is unclear, although natural killer (NK) cells play an important role in immune defense against tumor cells. Interactions between receptors on NK cells and ligands expressed by tumor cells are critical for tumor control by immunotherapy. In this study, we analyzed tumor samples from 54 MB patients for expression of major histocompatibility complex class I-related chains A (MICA) and UL16 binding protein (ULPB-2), which are ligands for the NK group 2 member D activatory receptor (NKG2D). The percentage of MICA and ULBP-2 positive cells was higher than 25% in 68% and 6% of MB patients, respectively. A moderate-high intensity of MICA cytoplasmic staining was observed in 46% MB patients and weak ULBP-2 staining was observed in 8% MB patients. No correlation between MICA/ULBP-2 expression and patient outcome was found. We observed that HTB-186, a MB cell line, was moderately resistant to NK cell cytotoxicity in vitro. Blocking MICA/ULBP-2 on HTB-186, and NKG2D receptor on NK cells increased resistance to NK cell lysis in vitro. However, HLA class I blocking on HTB-186 and overnight incubation with IL-15 stimulated NK cells efficiently killed tumor cells in vitro. We conclude that although NKG2D/MICA-ULBP-2 interactions have a role in NK cell cytotoxicity against MB, high expression of HLA class I can protect MB from NK cell cytotoxicity. Even so, our in vitro data indicate that if NK cells are appropriately stimulated, they may have the potential to target MB in vivo.
authors.affiliation: Department of Hemato-Oncology and Stem Cell Transplantation, Hospital Infantil Universitario Niño Jesús Madrid, Spain.
authors.forename: Lucia
authors.initials: L
authors.lastname: Fernández
authors.forename: Raquel
authors.initials: R
authors.lastname: Portugal
authors.forename: Jaime
authors.initials: J
authors.lastname: Valentín
authors.forename: Roberto
authors.initials: R
authors.lastname: Martín
authors.forename: Hannah
authors.initials: H
authors.lastname: Maxwell
authors.forename: Marta
authors.initials: M
authors.lastname: González-Vicent
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Díaz
authors.forename: Inmaculada
authors.initials: I
authors.lastname: de Prada
authors.forename: Antonio
authors.initials: A
authors.lastname: Pérez-Martínez
keywords: HLA-I; NKG2D ligands; NKG2D receptor; medulloblastoma; natural killer cells